Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)
Richard J. Edmondson(St. Mary's Hospital), Rachel O’Connell(National Health and Medical Research Council), Susana Banerjee(Royal Marsden NHS Foundation Trust), Linda Mileshkin(University of Melbourne), Peter Sykes(University of Otago), Philip Beale(Chris O’Brien Lifehouse), Ann D Fisher(Queen Elizabeth Hospital), Anthony Bonaventura(University of Newcastle Australia), David Millan(Queen Elizabeth University Hospital), Steven Nottley(UNSW Sydney), Charlotte Benson(Royal Marsden NHS Foundation Trust), Anne Hamilton(Peter MacCallum Cancer Centre), Katrin Marie Sjoquist(National Health and Medical Research Council), Laura E. Crotty Alexander(Cancer Research UK), Caroline Kelly(University of Glasgow), Karen Carty(Cancer Research UK), Laura Divers(Cancer Research UK Clinical Trials Unit), Nathan Bradshaw(National Health and Medical Research Council), Michael Friedländer(Royal Women's Hospital)
Cited by 15Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis